Sanofi ADR

Historical 13F Holders

Symbol
SNY
CUSIP
80105N105
All holders as of
Q2 2026
Type
Equity
Class
SPONSORED ADR
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 80105N105 since 12/18/2024, newest first.

Filer % of Class Filed
Amundi 13G/A Amendment 12
5.7% 7/22/2026
Event 6/30/2026
Amundi 13G/A Amendment 11
5.0% 4/10/2026
Event 3/31/2026
Amundi 13G/A Amendment 10
5.1% 2/17/2026
Event 12/31/2025
Amundi 13G/A Amendment 9
5.2% 11/14/2025
Event 9/30/2025
Amundi 13G/A Amendment 8
5.0% 8/13/2025
Event 6/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 24 217 k $8.85 M
2026 Q2 746 190 M $8.09 B
2026 Q1 768 210 M $10.1 B
2025 Q4 787 223 M $10.8 B
2025 Q3 748 241 M $11.4 B
2025 Q2 759 248 M $12.0 B
2025 Q1 804 260 M $14.4 B
2024 Q4 758 264 M $12.8 B
2024 Q3 788 284 M $16.4 B
2024 Q2 766 289 M $14.1 B
2024 Q1 740 278 M $13.5 B
2023 Q4 737 259 M $12.9 B
2023 Q3 718 252 M $13.5 B
2023 Q2 696 254 M $13.7 B
2023 Q1 704 273 M $14.5 B
2022 Q4 669 262 M $12.8 B
2022 Q3 629 255 M $9.71 B
2022 Q2 676 258 M $13.0 B
2022 Q1 646 252 M $12.9 B
2021 Q4 663 245 M $12.2 B
2021 Q3 600 237 M $11.4 B
2021 Q2 606 203 M $10.7 B
2021 Q1 592 197 M $9.77 B
2020 Q4 632 176 M $8.57 B
2020 Q3 597 174 M $8.74 B
2020 Q2 604 180 M $9.18 B
2020 Q1 573 187 M $8.21 B
2019 Q4 561 180 M $9.02 B
2019 Q3 508 179 M $8.28 B
2019 Q2 517 182 M $7.88 B
2019 Q1 515 181 M $8.04 B
2018 Q4 524 179 M $7.78 B
2018 Q3 508 179 M $8.01 B
2018 Q2 509 190 M $7.62 B
2018 Q1 516 214 M $8.60 B
2017 Q4 531 226 M $9.77 B
2017 Q3 518 229 M $11.5 B
2017 Q2 502 235 M $11.3 B
2017 Q1 487 254 M $11.5 B
2016 Q4 516 255 M $10.3 B
2016 Q3 480 253 M $9.73 B
2016 Q2 475 247 M $10.4 B
2016 Q1 474 233 M $9.39 B
2015 Q4 506 228 M $9.76 B
2015 Q3 523 242 M $11.5 B
2015 Q2 529 254 M $12.6 B
2015 Q1 540 258 M $12.9 B
2014 Q4 521 250 M $11.5 B
2014 Q3 525 244 M $13.8 B
2014 Q2 512 240 M $12.8 B
2014 Q1 518 236 M $12.4 B